The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant-Reference-Cited by-同舟云学术

The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant

Published:2002-11 Issue:9 Volume:64 Page:1387-1398
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Bapiro Tashinga E,Hasler Julia A,Ridderström Marianne,Masimirembwa Collen M

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference68 articles.

1. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians;Shimada;J. Pharmacol. Exp. Ther.,1994

2. Human cytochrome P450s: selectivity and measurement in vivo;Smith;Xenobiotica,1998

3. Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes;Vandel;Eur. J. Clin. Pharmacol.,1999

4. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians;Droll;Pharmacogenetics,1998

5. Hydroxylation polymorphism of debrisoquine and mephenytoin in European populations;Alvan;Eur. J. Clin. Pharmacol.,1990

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D6*17 and CYP2D6*29, When Compared with Normal Metabolizers;The Journal of Clinical Pharmacology;2023-10-25

2. Characterizing the combined effects of cytochrome P450 missense variation within star allele definitions;Pharmacogenomics;2023-07

3. Physiologically‐based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups;CPT: Pharmacometrics & Systems Pharmacology;2022-03-08

4. Substrate specificity of CYP2D6 genetic variants;Pharmacogenomics;2021-11

5. Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions;Pharmaceutics;2020-12-11